| mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.47 |
0.003 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.42 |
0.2 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.27 |
0.4 |
| mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.26 |
0.1 |
| mRNA |
BIBW2992 |
FIMM |
pan-cancer |
AAC |
-0.25 |
0.1 |
| mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
-0.24 |
0.2 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
3e-11 |
| mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
-0.23 |
0.2 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
1e-10 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
1e-09 |